irblog.prnewswire.com

AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European Union

- PRODUODOPA demonstrated sustained improvements in "Off" time (when symptoms return between medication doses), "On" time (when symptoms are controlled) without dyskinesia (involuntary movement), and ...
New York Post

Remarkable video shows UK dad with Parkinson’s Damien Gath before and after taking breakthrough drug: ‘Life-changing’

UK father Damien Gath received a new chance at life following a remarkable breakthrough treatment that helped manage his Parkinson’s disease. Gath was one of the first patients in the UK to be fitted ...
Nasdaq

AbbVie Announces Launch Of PRODUODOPA In The EU - Quick Facts

(RTTNews) - AbbVie (ABBV) announced the launch of PRODUODOPA in the European Union for the treatment of advanced Parkinson's disease with severe motor fluctuations and hyperkinesia or dyskinesia, and ...
streetinsider

AbbVie (ABBV) Launches PRODUODOPA in the EU

PRODUODOPA is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations in people living with advanced Parkinson's disease whose ...
Newsweek

Incredible Difference in Man With Parkinson’s Just Days After New Therapy

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Damien Gath is among the first people in the U.K. to experience a new ...
PharmaTimes

AbbVie’s Produodopa approved by SMC to treat Parkinson’s disease patients in Scotland

AbbVie’s Produodopa (foslevodopa-foscarbidopa) has been accepted by the Scottish Medicines Consortium (SMC) for use within NHS Scotland to treat advanced levodopa-responsive Parkinson’s disease (PD).
pharmaphorum

AbbVie’s 24-hour Parkinson’s therapy to roll out on NHS

Around 1,000 people with Parkinson’s disease will be able to access treatment with AbbVie’s Produodopa, the first therapy that can be delivered by a 24-hour ...
BBC

New Parkinson's drug Produodopa to be available on NHS

Nearly 1,000 people with advanced Parkinson's disease are to benefit from a new treatment that involves wearing a portable kit 24 hours day. NHS England is to roll out the treatment, Produodopa, which ...
Nasdaq

AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European Union

- PRODUODOPA® (foslevodopa/foscarbidopa) is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of advanced Parkinson's ...
Mena FN

Abbvie Launches PRODUODOPA® (Foslevodopa/Foscarbidopa) For People Living With Advanced Parkinson's Disease In The European Union

PRODUODOPA is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations in people living with advanced Parkinson's disease whose ...
Pharmabiz

AbbVie introduces Produodopa in European Union to treat people living with advanced Parkinson's disease

AbbVie announced the launch of Produodopa (foslevodopa/foscarbidopa) in the European Union for the treatment of advanced Parkinson's disease with severe motor ...